Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients
    Cai, Yunshi
    Zhang, Bohan
    Li, Jiaxin
    Li, Hui
    Liu, Hailing
    Xie, Kunlin
    Du, Chengyou
    Wu, Hong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Development and Validation of Nomograms to Predict the Overall Survival and Progression-Free Survival in Patients with Advanced Unresectable Intrahepatic Cholangiocarcinoma
    Xian, Feng
    Song, Xuewu
    Bie, Jun
    Xu, Guohui
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1835 - 1849
  • [23] Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
    Ogawa, Chikara
    Morita, Masahiro
    Omura, Akina
    Noda, Teruyo
    Kubo, Atsushi
    Matsunaka, Toshihiro
    Tamaki, Hiroyuki
    Shibatoge, Mitsushige
    Tsutsui, Akemi
    Senoh, Tomonori
    Nagano, Takuya
    Takaguchi, Kouichi
    Tani, Joji
    Morishita, Asahiro
    Yoneyama, Hirohito
    Masaki, Tsutomu
    Moriya, Akio
    Ando, Masaharu
    Deguchi, Akihiro
    Kokudo, Yasutaka
    Minami, Yasunori
    Ueshima, Kazuomi
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 113 - 119
  • [24] Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival
    Carbognin, Luisa
    Sperduti, Isabella
    Ciccarese, Mariangela
    Fabi, Alessandra
    Petrucelli, Luciana
    Vari, Sabrina
    Forcignano, Rosa Chiara
    Nortilli, Rolando
    Vicentini, Cecilia
    Pilotto, Sara
    Merler, Sara
    Zampiva, Ilaria
    Brunelli, Matteo
    Manfrin, Erminia
    Giannarelli, Diana
    Tortora, Giampaolo
    Bria, Emilio
    BREAST, 2016, 29 : 24 - 30
  • [25] Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study
    Zhang, Haofeng
    Li, Qingshan
    Huang, Guan
    Yang, Zhenwei
    Chen, Kunlun
    Meng, Bo
    Yu, Haibo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
    Imai, Hisao
    Mori, Keita
    Wakuda, Kazushige
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANNALS OF THORACIC MEDICINE, 2015, 10 (01) : 61 - 66
  • [27] Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
    Li, Jiayi
    Cao, Dongyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Clinical Impact of Post-Progression Survival for Overall Survival in Patients with Sensitive Relapse of Small Cell Lung Cancer
    Miura, Yosuke
    Imai, Hisao
    Yoshino, Reiko
    Fujimoto, Sakae
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Minato, Koichi
    Hisada, Takeshi
    Saito, Ryusei
    Yamada, Masanobu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S741 - S742
  • [29] The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer
    Miura, Yosuke
    Imai, Hisao
    Sakurai, Reiko
    Kaira, Kyoichi
    Sunaga, Noriaki
    Minato, Koichi
    Saito, Ryusei
    Hisada, Takeshi
    MEDICAL ONCOLOGY, 2018, 35 (04)
  • [30] The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer
    Yosuke Miura
    Hisao Imai
    Reiko Sakurai
    Kyoichi Kaira
    Noriaki Sunaga
    Koichi Minato
    Ryusei Saito
    Takeshi Hisada
    Medical Oncology, 2018, 35